Effect of donor–recipient cytomegalovirus serologic status on outcomes in simultaneous kidney–pancreas transplant recipients
- 1 May 2004
- journal article
- clinical trial
- Published by Elsevier in Transplantation Proceedings
- Vol. 36 (4) , 1082-1083
- https://doi.org/10.1016/j.transproceed.2004.04.066
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Two-dose daclizumab regimen in simultaneous kidney-pancreas transplant recipients: primary endpoint analysis of a multicenter, randomized study1Transplantation, 2003
- Patterns of cytomegalovirus infection in simultaneous kidney–pancreas transplant recipients receiving tacrolimus, mycophenolate mofetil, and prednisone with ganciclovir prophylaxisTransplant Infectious Disease, 2001
- Infection in Organ-Transplant RecipientsNew England Journal of Medicine, 1998